Research misconduct rife in Clinical Trials

A major study from New York Institute of Journalism member Charles Seife, M.S has reported that nearly half of the clinical trials approved by the FDA in the USA (which is a gateway for UK approvals) had ‘significant departures’ from accepted standards – these included under-reporting of adverse events, violations of recruitment guidelines, inadequate record keeping, failure to respect the safety, welfare and rights of patients, institutional review board oversights and violations of best practice protocols.

Within the overall picture, the FDA reported on 57 trials of which 22 contained data that was falsified (nearly 40 per cent).

So much for rigorous testing.

Ref: http://archinte.jamanetwork.com/article.aspx?articleID=2109855

, , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *

*

HTML tags are not allowed.